Loading...

Archive

    02 March 2019, Volume 35 Issue 3 Previous Issue    Next Issue

    For Selected: Toggle Thumbnails
    Epidemiological features of polycystic ovary syndrome.
    YUAN Ying-ying,ZHAO Jun-li
    2019, 35(3): 261-264.  DOI: 10.19538/j.fk2019030102
    Abstract ( )  

    Polycystic ovary syndrome is a common metabolic dysfunction and heterogeneous endocrine disorder.Epidemiological reports on the prevalence and clinical symptoms of polycystic ovary syndrome in different countries and regions are different.This paper reviews studies of epidemiological features of polycystic ovary syndrome and expound them.

    Interpretation of diagnosis criteria for polycystic ovary syndrome.
    QIAN Yi,MA Xiang
    2019, 35(3): 265-267.  DOI: 10.19538/j.fk2019030103
    Abstract ( )  

    The clinical manifestations of polycystic ovary syndrome(PCOS)are highly heterogeneous.The diagnosis and treatment of PCOS are still controversial,and the treatment methods are different.In 2018,the Gynecological Endocrinology Group of Chinese Medical Association of Obstetrics and Gynecology organized domestic experts to formulate the "Guidelines for Diagnosis and Treatment of Polycystic Ovarian Syndrome" in China.This article will interpret the diagnosis criteria and the evidence of this Guidelines for childbearing age women by combining with foreign consensus and literature.

    Diagnosis classification and clinical significance of polycystic ovarian syndrome.
    LIN Jia,JIANG Qi
    2019, 35(3): 267-271.  DOI: 10.19538/j.fk2019030104
    Abstract ( )  

    Polycystic ovary syndrome(PCOS)is characterized by diverse clinical manifestations and big individual differences.Through the diagnosis classification of PCOS,attention is paid to the different clinical features,biochemical characteristics and risk of long-term metabolic complications of PCOS patients,which is conducive to the individualized treatment and long-term management of patients.

    Differential diagnosis of polycystic ovary syndrome.
    LU Qun,ZHAO Lu-lu
    2019, 35(3): 271-274.  DOI: 10.19538/j.fk2019030105
    Abstract ( )  

    Polycystic ovary syndrome(PCOS)is the most common endocrine and metabolic disorder of childbearing-age women,with clinical symptoms including ovulatory dysfunction and hyperandrogenism.Diagnosis of PCOS must exclude other causes of ovulation disorders and hyperandrogenism.

    Characteristics and management of PCOS-related hyperandrogenism.
    ZHU Xi,NI Hao
    2019, 35(3): 274-278.  DOI: 10.19538/j.fk2019030106
    Abstract ( )  

    Hyperandrogenism is one of the major clinical characteristics of PCOS,which can be assessed either by biochemical determination of hyperandrogenism or clinical manifestations of hyperandrogenism to make diagnosis.Hyperandrogenism leads to ovulatory dysfunction and menstrual disorder by affecting follicular development,and causes hirsutism and acne as well;it is closely associated with the development of endometrial cancers,diabetes and cardiovascular diseases from the long-term perspective.Therefore,it is imperative to fully understand characteristics and management of PCOS-related hyperandrogenism,which is an important part of the comprehensive therapy for PCOS.

    Metabolic characteristics and management of polycystic ovary syndrome during pregnancy.
    LI Guang-hui,LUO Jin-ying
    2019, 35(3): 278-283.  DOI: 10.19538/j.fk2019030107
    Abstract ( )  

    Polycystic ovary syndrome(PCOS)is the most common endocrine and metabolic disorders in women of childbearing age,which may have adverse effects on both pregnant and non-pregnant women.In recent years,it has been found that PCOS appears to  increase risks of developing adverse outcomes,which may be related to insulin resistance,obesity,glucose and lipid metabolic disorders and hyperandrogenism.Proper management of PCOS in prepregnancy,pregnancy and postpartum might play important roles in the prevention of short-term and long-term complications.The metabolic characteristics and management of PCOS are reviewed in this article.

    Screening tests and managements of glucolipid metabolic disorders in PCOS.
    CHEN Li-na,GUAN Wen-zheng
    2019, 35(3): 283-286.  DOI: 10.19538/j.fk2019030108
    Abstract ( )  

    Polycystic ovary syndrome(PCOS)is one of the most common endocrine disorders in women,which is associated with metabolic abnormalities and long-term complications including diabetes and cardiovascular diseases.When diagnosed with PCOS,patients need to undergo screening tests on glycolipid metabolism in time,in order to conduct early intervention to reduce the cardiovascular and diabetic risk.Managements of glycolipid metabolic disorders in PCOS should be based on the characteristics of different phenotypes and patients' needs in order to perform individual treatments.

    Treatment of obese patients with polycystic ovary syndrome before assisted reproduction.
    LUO Zhuo-ye,ZHANG Jie
    2019, 35(3): 287-291.  DOI: 10.19538/j.fk2019030109
    Abstract ( )  

    Polycystic ovary syndrome(PCOS)is a common disease with endocrinal disorder in fertile women,which is usually characterized by anovulation,hyperandrogenism and insulin resistance.Endocrinal disorders make patients with PCOS be prone to develop obesity.Obesity interacts with PCOS,and they both increase the risk of infertility,pregnancy complications and long-term complications.Thus,the patient needs to undergo health status assessment,lifestyle modification,medications or even surgery before assisted reproduction in order to improve the outcomes of assisted reproduction and reduce the risk of pregnancy complications and long-term complications.

    Screening and management of polycystic ovary syndrome in adolescence.
    LI Lin,YANG Dong-zi
    2019, 35(3): 291-295.  DOI: 10.19538/j.fk2019030110
    Abstract ( )  

    Polycystic ovary syndrome is one of the common gynecological endocrine diseases.The mechanism is unclear.Many patients of polycystic ovary syndrome have their first onsets during adolescence,who may encounter various problems in reproduction and metabolism later,including infertility,spontaneous abortion and gestational diabetes.We summarized the early screening and management of polycystic ovary syndrome in adolescence.

    Psychological problems and management in polycystic ovary syndrome.
    LI Xin
    2019, 35(3): 295-297.  DOI: 10.19538/j.fk2019030111
    Abstract ( )  

    Mild to moderate depression and anxiety symptoms distinguished women with PCOS.Gynecologists should be aware of the risks about co-occurrence of PCOS with depression and anxiety symptoms,measure them with self-Rating questionnaires and transfer them to psychologists.Long term multidisciplinary treatment and research about the psychological characteristics in PCOS women is important.